UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

AKT1 Activation Promotes Development of Melanoma Metastases

Cell reports (Cambridge), 2015-11, Vol.13 (5), p.898-905

2015

Volltextzugriff (PDF)

Mutant IDH1 Promotes Glioma Formation In Vivo

Cell reports (Cambridge), 2018-05, Vol.23 (5), p.1553-1564

2018

Volltextzugriff (PDF)

BRAF inhibition in melanoma is associated with the dysregulation of histone methylation and histone methyltransferases

Neoplasia (New York, N.Y.), 2020-09, Vol.22 (9), p.376-389

2020

Volltextzugriff (PDF)

Prior Exposure to Coxsackievirus A21 Does Not Mitigate Oncolytic Therapeutic Efficacy

Cancers, 2021-09, Vol.13 (17), p.4462

2021

Volltextzugriff (PDF)

Mitogen-Activated Protein Kinase Inhibition Induces Translocation of Bmf to Promote Apoptosis in Melanoma

Cancer research (Chicago, Ill.), 2009-03, Vol.69 (5), p.1985-1994

2009

Volltextzugriff (PDF)

AKT1E17K Activates Focal Adhesion Kinase and Promotes Melanoma Brain Metastasis

Molecular cancer research, 2019-09, Vol.17 (9), p.1787-1800

2019

Volltextzugriff (PDF)

ASA Suppresses PGE2 in Plasma and Melanocytic Nevi of Human Subjects at Increased Risk for Melanoma

Pharmaceuticals (Basel, Switzerland), 2020-01, Vol.13 (1), p.7

2020

Volltextzugriff (PDF)

Aspirin Protects Melanocytes and Keratinocytes against UVB-Induced DNA Damage In Vivo

Journal of investigative dermatology, 2021-01, Vol.141 (1), p.132-141.e3

2021

Volltextzugriff (PDF)

Aspirin Suppresses PGE2 and Activates AMP Kinase to Inhibit Melanoma Cell Motility, Pigmentation, and Selective Tumor Growth In Vivo

Cancer prevention research (Philadelphia, Pa.), 2018-10, Vol.11 (10), p.629-642

2018

Volltextzugriff (PDF)

Genetic Silencing of AKT Induces Melanoma Cell Death via mTOR Suppression

Molecular cancer therapeutics, 2024-03, Vol.23 (3), p.301-315

2024

Volltextzugriff (PDF)

A phase I study of intratumoral ipilimumab and interleukin-2 in patients with advanced melanoma

Oncotarget, 2016-09, Vol.7 (39), p.64390-64399

2016

Volltextzugriff (PDF)

Model of the TVA receptor determinants required for efficient infection by subgroup A avian sarcoma and leukosis viruses

Journal of virology, 2015-02, Vol.89 (4), p.2136-2148

2015

Volltextzugriff (PDF)

Mitogen-activated protein kinase pathway-dependent tumor-specific survival signaling in melanoma cells through inactivation of the proapoptotic protein Bad

Cancer research (Chicago, Ill.), 2003-12, Vol.63 (23), p.8330-8337

2003

Volltextzugriff (PDF)

Resistance mechanisms to genetic suppression of mutant NRAS in melanoma

Melanoma research, 2017-12, Vol.27 (6), p.545-557

2017

Volltextzugriff (PDF)

Inhibition of avian leukosis virus replication by vector-based RNA interference

Virology (New York, N.Y.), 2007-09, Vol.365 (2), p.464-472

2007

Volltextzugriff (PDF)

Ink4a/Arf loss promotes tumor recurrence following Ras inhibition

Neuro-oncology (Charlottesville, Va.), 2012-01, Vol.14 (1), p.34-42

2012

Volltextzugriff (PDF)

Akt signaling accelerates tumor recurrence following ras inhibition in the context of ink4a/arf loss

Genes & cancer, 2013-11, Vol.4 (11-12), p.476-485

2013

Volltextzugriff (PDF)

Akt signaling is required for glioblastoma maintenance in vivo

American journal of cancer research, 2011-01, Vol.1 (2), p.155-167

2011

Volltextzugriff (PDF)

Targeted delivery of NRASQ61R and Cre-recombinase to post-natal melanocytes induces melanoma in Ink4a/Arflox/lox mice

Pigment cell and melanoma research, 2010-08, Vol.23 (4), p.531-541

2010

Volltextzugriff (PDF)

HBEGF promotes gliomagenesis in the context of Ink4a/Arf and Pten loss

Oncogene, 2017-08, Vol.36 (32), p.4610-4618

2017

Volltextzugriff (PDF)

Met amplification and tumor progression in Cdkn2a-deficient melanocytes

Pigment cell and melanoma research, 2009-08, Vol.22 (4), p.454-460

2009

Volltextzugriff (PDF)

Activated BRAF induces gliomas in mice when combined with Ink4a/Arf loss or Akt activation

Oncogene, 2010-01, Vol.29 (3), p.335-344

2010

Volltextzugriff (PDF)

Abstract 2736: AKT1E17K activates focal adhesion kinase and promotes melanoma brain metastasis

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.2736-2736

2020

Volltextzugriff (PDF)

Abstract 2438: Defining the role of mutant isocitrate dehydrogenase in malignant glioma

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.2438-2438

2014

Volltextzugriff (PDF)

Activated MEK cooperates with Ink4a/Arf loss or Akt activation to induce gliomas in vivo

Oncogene, 2011-03, Vol.30 (11), p.1341-1350

2011

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(35)
Dissertationen
(1)

Sprache

Englisch
(36)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(18)
Science & Technology
(18)
Oncology
(14)
Humans
(13)
Animals
(12)
Mice
(10)
Melanoma - Pathology
(8)
Cell Biology
(7)
Cell Line, Tumor
(7)
Cyclin-Dependent Kinase Inhibitor P16 - Genetics
(7)
Glioma
(6)
Cyclin-Dependent Kinase Inhibitor P16 - Metabolism
(5)
Melanoma
(5)
Melanoma - Genetics
(5)
Tumors
(5)
Biological And Medical Sciences
(4)
Brain Neoplasms - Genetics
(4)
Brain Neoplasms - Metabolism
(4)
Dermatology
(4)
Glioma - Genetics
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

AKT1 Activation Promotes Development of Melanoma Metastases

Mutant IDH1 Promotes Glioma Formation In Vivo

BRAF inhibition in melanoma is associated with the dysregulation of histone methylation and histone methyltransferases

Prior Exposure to Coxsackievirus A21 Does Not Mitigate Oncolytic Therapeutic Efficacy

Mitogen-Activated Protein Kinase Inhibition Induces Translocation of Bmf to Promote Apoptosis in Melanoma

AKT1E17K Activates Focal Adhesion Kinase and Promotes Melanoma Brain Metastasis

ASA Suppresses PGE2 in Plasma and Melanocytic Nevi of Human Subjects at Increased Risk for Melanoma

Aspirin Protects Melanocytes and Keratinocytes against UVB-Induced DNA Damage In Vivo

Aspirin Suppresses PGE2 and Activates AMP Kinase to Inhibit Melanoma Cell Motility, Pigmentation, and Selective Tumor Growth In Vivo

Genetic Silencing of AKT Induces Melanoma Cell Death via mTOR Suppression

A phase I study of intratumoral ipilimumab and interleukin-2 in patients with advanced melanoma

Model of the TVA receptor determinants required for efficient infection by subgroup A avian sarcoma and leukosis viruses

Mitogen-activated protein kinase pathway-dependent tumor-specific survival signaling in melanoma cells through inactivation of the proapoptotic protein Bad

Resistance mechanisms to genetic suppression of mutant NRAS in melanoma

Inhibition of avian leukosis virus replication by vector-based RNA interference

Ink4a/Arf loss promotes tumor recurrence following Ras inhibition

Akt signaling accelerates tumor recurrence following ras inhibition in the context of ink4a/arf loss

Akt signaling is required for glioblastoma maintenance in vivo

Targeted delivery of NRASQ61R and Cre-recombinase to post-natal melanocytes induces melanoma in Ink4a/Arflox/lox mice

HBEGF promotes gliomagenesis in the context of Ink4a/Arf and Pten loss

Met amplification and tumor progression in Cdkn2a-deficient melanocytes

Activated BRAF induces gliomas in mice when combined with Ink4a/Arf loss or Akt activation

Abstract 2736: AKT1E17K activates focal adhesion kinase and promotes melanoma brain metastasis

Abstract 2438: Defining the role of mutant isocitrate dehydrogenase in malignant glioma

Activated MEK cooperates with Ink4a/Arf loss or Akt activation to induce gliomas in vivo

Suchergebnisse filtern